A detailed history of Morgan Stanley transactions in Absci Corp stock. As of the latest transaction made, Morgan Stanley holds 501,706 shares of ABSI stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
501,706
Previous 133,176 276.72%
Holding current value
$1.28 Million
Previous $410,000 367.32%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.97 - $4.49 $1.09 Million - $1.65 Million
368,530 Added 276.72%
501,706 $1.92 Million
Q2 2024

Oct 17, 2024

BUY
$2.92 - $6.58 $2,327 - $5,244
797 Added 0.6%
133,176 $410,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $2,327 - $5,244
797 Added 0.6%
133,176 $410,000
Q1 2024

Oct 17, 2024

SELL
$3.41 - $5.74 $2,717 - $4,574
-797 Reduced 0.6%
132,379 $751,000
Q1 2024

Aug 16, 2024

BUY
$3.41 - $5.74 $286,811 - $482,785
84,109 Added 174.25%
132,379 $751,000
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $286,811 - $482,785
84,109 Added 174.25%
132,379 $751,000
Q4 2023

Aug 16, 2024

SELL
$1.15 - $4.79 $97,641 - $406,699
-84,906 Reduced 63.75%
48,270 $202,000
Q4 2023

Feb 13, 2024

BUY
$1.15 - $4.79 $868 - $3,616
755 Added 1.59%
48,270 $202,000
Q3 2023

Nov 15, 2023

SELL
$1.28 - $2.41 $60,971 - $114,797
-47,634 Reduced 50.06%
47,515 $62,000
Q2 2023

Aug 14, 2023

SELL
$1.17 - $2.03 $25,740 - $44,659
-22,000 Reduced 18.78%
95,149 $144,000
Q1 2023

May 15, 2023

BUY
$1.58 - $3.41 $14,016 - $30,250
8,871 Added 8.19%
117,149 $205,000
Q4 2022

Feb 14, 2023

BUY
$2.0 - $3.58 $37,412 - $66,967
18,706 Added 20.88%
108,278 $227,000
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $107,648 - $176,251
36,491 Added 68.75%
89,572 $280,000
Q2 2022

Oct 27, 2022

BUY
$3.13 - $8.83 $89,114 - $251,398
28,471 Added 115.69%
53,081 $176,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $8.83 $89,114 - $251,398
28,471 Added 115.69%
53,081 $176,000
Q1 2022

Oct 27, 2022

SELL
$5.87 - $9.46 $167,124 - $269,335
-28,471 Reduced 53.64%
24,610 $208,000
Q1 2022

May 13, 2022

BUY
$5.87 - $9.46 $42,933 - $69,190
7,314 Added 42.29%
24,610 $208,000
Q4 2021

Feb 14, 2022

BUY
$7.88 - $18.03 $113,322 - $259,289
14,381 Added 493.34%
17,296 $141,000
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $30,228 - $88,295
2,915 New
2,915 $34,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $237M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.